Experienced in Liver Failure

Dina H. Kao

Edmonton, AB, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Liver Failure
Edmonton, AB, CA 
OverviewLocationsClinical Research

Overview

Dina Kao practices in Edmonton, Canada. Ms. Kao is rated as an Experienced expert by MediFind in the treatment of Liver Failure. Her top areas of expertise are Pseudomembranous Colitis, Viral Gastroenteritis, Crohn's Disease, Colonoscopy, and Endoscopy.

Her clinical research consists of co-authoring 76 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles and participated in 1 clinical trial in the study of Liver Failure.

Gender
Female

Locations

Edmonton, AB, Canada
Other Locations
AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Fecal Microbiota Transplant National Registry
Fecal Microbiota Transplant National Registry
Enrollment Status: Recruiting
Publish Date: January 29, 2025
Intervention Type: Other
A Randomized Double-blind, Placebo-controlled Trial of Lyophilized Fecal Microbiota Transplantation for the Induction of Remission in Adults With Active Ulcerative Colitis
A Randomized Double-blind, Placebo-controlled Trial of Lyophilized Fecal Microbiota Transplantation for the Induction of Remission in Adults With Active Ulcerative Colitis
Enrollment Status: Withdrawn
Publish Date: May 10, 2023
Intervention Type: Biological, Other
Study Drug: Fecal Microbiota Transplant
Study Phase: Phase 2
A Prospective, Single Center, Open Label Trial of Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study
A Prospective, Single Center, Open Label Trial of Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study
Enrollment Status: Completed
Publish Date: October 04, 2021
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Phase I, Open-Label, Single-Centre Study of the Safety and Efficacy of MET-2 in Patients With Recurrent Clostridium Difficile Infection (CDI)
A Phase I, Open-Label, Single-Centre Study of the Safety and Efficacy of MET-2 in Patients With Recurrent Clostridium Difficile Infection (CDI)
Enrollment Status: Completed
Publish Date: August 11, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

76 Total Publications

More Than Meets the Eye: Interpreting Results of a Negative Trial.
More Than Meets the Eye: Interpreting Results of a Negative Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Kao's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile